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Abstract: When designing clinical trials for testing novel cardiovascular therapies, it is highly relevant to 
understand what a given technology can provide in terms of information on the physiologic status of the heart 
and vessels. Ultrasound imaging has traditionally been the modality of choice to study the cardiovascular 
system as it has an excellent temporal resolution; it operates in real-time; it is very widespread and – not unimportant – it 
is cheap. Although this modality is mostly known clinically as a two-dimensional technology, it has recently matured into 
a true three-dimensional imaging technique. In this review paper, an overview is given of the available ultrasound 
technology for cardiac chamber quantification in terms of volume and function and evidence is given why these 
parameters are of value when testing the effect of new cardiovascular therapies. 
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1. MOTIVATION 
 The current global status of cardiovascular diseases, 
accounting for more deaths than any other cause [1] and 
projected to remain the leading global cause of death [2], 
makes the assessment of cardiac volume and function a topic 
of extreme importance not only in the clinical field for 
patient diagnostic and follow-up but also in research as new 
therapies are developed and tested. Several cardiac imaging 
modalities have arisen to satisfy the demand for cardiac 
function assessment techniques, among which three-
dimensional (3D) echocardiography seems to be especially 
promising. The analysis of the images to obtain the 
volumetric indices has also been heavily developed in order 
to extract the information in a fast, exact and user-
independent manner. 
While much research and clinical attention has been 
directed towards volumetric assessment of the left ventricle 
(LV), as detailed in the extensive review of Leung and 
Bosch, an increased interest in the other cardiac chambers is 
more recently shifting the focus towards a more 
comprehensive set of volumetric biomarkers [3]. Thus, this 
present review presents an accurate description of the current 
state-of-the-art on cardiac chamber volumetric assessment 
using three-dimensional ultrasound. The focus is set on the 
available technologies in clinical practice, as well as the 
most relevant validation efforts for each cardiac chamber. 
This manuscript is organized as follows: Section 2 
provides a global perspective on the importance of 
volumetric cardiac indices and how these can be effectively 
assessed. The main existing modalities for cardiac imaging 
are also presented and compared. A brief conceptual 
description of the available methods for cardiac image  
*Address correspondence to this author at the Medical Imaging Research 
Center, University Hospital Gasthuisberg, Herestraat 49 – bus 7003, B-3000 
Leuven, Belgium. E-mail: joao.pedrosa@kuleuven.be 
processing and automated  volumetric  assessment  is  then  
given in Section 3. Section 4 focuses then on the available 
software solutions in clinical practice for volumetric 
biomarkers of cardiac morphology and function for each 
chamber, while discussing their validation level and relevant 
clinical findings. Finally, Section 5 concludes the current 
manuscript with the closing remarks on this topic discussing 
the present and future challenges for cardiac chamber 
volumetric assessment. 
2. ASSESSMENT OF CARDIAC MORPHOLOGY AND 
FUNCTION 
The fundamental cardiac pumping function arises from 
a sequence of electrical events which trigger the coordinated 
contraction of the myocardial tissue. These events form the 
cardiac cycle and are regularly repeated over every heartbeat, 
being regulated through different pacing mechanisms which 
control the frequency of cardiac contraction. The rhythmic 
contraction of the different cardiac chambers results in 
intrinsic volume variations of both atria and ventricles over 
the cardiac cycle.  From these volume traces, several indices 
can be extracted to characterize both cardiac morphology 
and global function such as the end-diastolic and end-
systolic volumes (EDV and ESV). In the particular case of 
the atria these volumes are often referred to as LAmax and 
LAmin and RAmax and RAmin for the left and right atrium 
(LA and RA)  respectively. It is also common practice to use 
volume indices divided by body surface area, usually the LA 
volume index (LAVI) and the RA volume index (RAVI). 
Furthermore, other cardiac global functional indices can be 
extracted from volume traces. Stroke volume (SV=EDV-
ESV) is the effective amount of blood ejected by a cavity. 
The left ventricular SV, when multiplied by the heart rate, 
gives the total cardiac output (CO). As a measure of 
pumping efficiency, one can estimate the ejection fraction 
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al. [4], which is still probably the most widely used 
parameter to assess the global status of cardiac function in 
LV [5]. For the atria, this measure is also called emptying 
fraction. Some specific measures have been proposed for the 
function assessment in the case of the atria such as the atrial 
expansion index (LAEI = LASV / LAmin and RAEI = 
RASV / RAmin). Moreover, atrial volume measured 
immediately before the atrial contraction (LApreA or 
RApreA) can be used to derive the passive (EFpass = (EDV 
- preA) / preA) and active (EFact  = (preA - ESV) / ESV) 
components of EF, the former corresponding to the passive 
emptying resulting from ventricle expansion (atrial conduit 
function) while the latter corresponds to the active emptying 
(atrial contractile function) [6]. 
2.1. Prognostic value in clinical practice 
Extensive research has been directed at determining the 
prognostic value of volumetric indices for different illnesses 
and conditions. A brief review of some of these studies is 
presented here to illustrate the importance of cardiac volume 
and function assessment. 
2.1.1. Left Ventricle 
Patient survival after myocardial infarction and its 
relation to LV function has been thoroughly described in 
literature. It was first associated with LV ESV by White et 
al. [7] and Norris et al. [8]. In a study by Burns et al., it was 
shown that LV EF had even a superior prognostic value than 
LV ESV for survival after myocardial infarction [9]. 
Numerous other studies have given further evidence on the 
prognostic value of LV EF on both short- and long-term 
survival after myocardial infarction [10–14]. Furthermore, 
LV EF has been linked to cardiac arrest events [13], heart 
failure [15], and arrhythmia suppression and cardiac events 
[16] in survivors of myocardial infarction. More generally, 
mortality in patients with coronary artery disease has also 
been associated with LV EF by Buxton et al. [17]. 
The prognostic value of LV EF for the mortality in 
patients with heart failure has also been a subject of much 
research and discussion with different studies reaching 
different conclusions as to which population, preserved or 
reduced LV EF, represents a higher mortality risk [18,19]. 
More recently, two meta-analysis studies, one by Somaratne 
et al.  and a second by a large-scale project (MAGGIC), 
analyzed data from 17 and 31 studies respectively 
demonstrating that a higher risk of death is present in 
patients with heart failure and reduced LV EF [20,21]. 
LV function has also been used as a predictor of 
survival in dilated cardiomyopathy [22,23]. Furthermore, LV 
EF has been associated to mortality in patients with LV 
dysfunction [24] and to mortality in end-stage renal disease 
patients on starting hemodialysis [25]. Some works have also 
been dedicated to the study of stress and post-stress LV 
volumes. In Sharir et al. post-exercise LV EF and ESV were 
associated to cardiac death [26] and in Coletta et al. 
dobutamine stress testing was used to link stress LV EDV to 
cardiac events in patients with coronary heart disease [27]. 
2.1.2. Left Atrium 
More recently the attention has shifted towards the 
prognostic value of LA volume and function. LA volume has 
been associated with diastolic dysfunction by Tsang et al. 
and also with LV remodeling by Rossi et al. [28,29]. It has 
also been linked to the onset of cardiovascular diseases [30], 
future cardiovascular events [31], to the development of 
congestive heart failure in patients with well-preserved LV 
function [32] and to the occurrence of ischemic stroke in 
patients without atrial fibrillation [33]. In a study by Leung 
et al., LAVI has been associated with the risk of 
cardiovascular death, heart failure, atrial fibrillation, stroke 
and myocardial infarction [34] and Ristow et al. have 
associated it to heart failure hospitalization and mortality 
[35]. LAVI has also been linked to the survival after 
myocardial infarction [36,37] and to cardiovascular events in 
patients with lone atrial fibrillation by Osranek et al. [38]. 
Finally, LA volume has been shown to have a prognostic 
value for atrial fibrillation [39,40]. 
2.1.3. Right Ventricle 
Some research has also been done into the prognostic 
value of the right heart, and especially of the right ventricle 
(RV). Numerous studies relate RV function, and more 
precisely RV EF, with patient survival in different stages of 
heart failure [41–45]. 
The prognostic value of the RV for survival in patients 
with pulmonary arterial hypertension has also been well 
explored in the studies by van Wolferen et al. [46]and van 
der Veerdonk et al. [47]. Furthermore, the post myocardial 
infarction mortality has been associated to the RV EF 
measured late after clinical myocardial infarction [48]. RV 
EF has also been associated with survival in patients with 
idiopathic dilated cardiomyopathy [49]. Finally, in a study 
by Kang et al., the early death of patients with acute 
pulmonary embolism has been associated to the ratio 
between the RV and the LV volumes [50]. 
2.1.4. Right Atrium 
The prognostic value of RA has been substantially less 
explored in literature. RAVI was linked to RV systolic 
dysfunction in patients with chronic systolic heart failure and 
abnormal RV function by Sallach et al. [51]. 
2.2. Available Imaging Modalities 
From the above, it is clear that the assessment of 
cardiac volumes throughout the cardiac cycle and its 
associated indices is a fundamental task in diagnostic 
cardiology routine. Furthermore, these indices can be of 
paramount importance in the design of studies to show the 
efficacy of new therapies. To this end, there is a large array 
of imaging modalities providing insight to cardiac chamber 
size and function, with some examples shown in Figure 1. 
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Figure 1. Examples of different cardiac imaging modalities: magnetic resonance imaging (a), computed tomography (b), 2-dimensional 
echocardiography (c) and 3D echocardiography (d). Computed tomography image courtesy of Walter Coudyzer, Department of 
Radiology, UZ Leuven, Belgium.
Magnetic resonance imaging (MRI), and more 
specifically cardiac MRI (cMRI), is for long considered the 
gold standard for assessment of cardiac anatomy and 
analysis of global cardiac function and shape [52]. The key 
limitations of cMRI are the high cost of the imaging system 
and the long acquisition times. This last problem is 
particularly relevant for cardiac imaging, given the fast 
dynamics of a beating heart. Computed tomography (CT) is 
one of the fastest evolving imaging modalities. Cardiac CT, 
which requires the use of contrast agents, offers superb 
definition of the boundary between the myocardium and the 
blood pool, excellent spatial resolution (<1mm) and good 
temporal resolution. However, it is a very technically 
demanding exam, involves exposure to ionizing radiation 
and is very expensive. Other imaging modalities used 
include cardiac single photon emission computed 
tomography (SPECT) and multiple gated imaging strategies 
(MUGA), also known as radionuclide ventriculography 
[53,54], positron emission tomography (PET) [55] and other 
nuclear imaging techniques [56]. However, these techniques 
require the injection of radioactive contrast agents, thus 
involving exposure to ionizing radiation, and the imaging 
systems are typically extremely expensive. 
With the exception of standard X-ray exams, ultrasound 
is the leading imaging modality worldwide [57]. As key 
imaging advantages, the excellent temporal resolution clearly 
sets echocardiography apart from the remaining modalities. 
Other important advantages, such as its safety, good spatial 
resolution and low cost, also contribute to the widespread 
use of echocardiography as the cardiac imaging diagnostic 
exam of reference in daily practice. The use of 
echocardiography to assess cardiac chamber size and 
function dates to the advent of this technology. Popp et al. 
investigated the variation of cardiac dimensions during the 
cardiac cycle using M-mode echocardiography [58]. 
Feigenbaum et al. used these changes to assess LV function 
and correlated it to angiography [59]. Wyatt et al. showed 
that volumetric indices extracted from two-dimensional (2D) 
B-mode images were superior to their M-mode counterparts, 
especially in asymmetrical hearts [60,61]. Currently, biplane 
area assessment using 2D echo is the standard tool for 
assessment of LV volumetric indices. 
2.3. Real-time 3D echocardiography 
Given the considerations previously mentioned, it 
becomes clear why current clinical practice in cardiology 
typically employs 2D echocardiographic studies as the first-
line and fundamental exam in the evaluation of cardiac 
function and morphology of patients, while cMRI is used as 
a second-line solution for more advanced investigation.  
Nonetheless, conventional 2D presents important 
limitations that directly reduce its potential for accurate 
volumetric assessment of the different cardiac chambers. 
Indeed, volume estimation from 2D ultrasound images 
intrinsically relies on geometric assumptions, which are 
required to transform the planar measurements into volume 
estimates. Since the imaging planes may correspond to 
foreshortened views of the real 3D object, the geometrical 
assumptions can be easily violated, which in turn leads to 
reduced accuracy in the volume estimates. Furthermore, 
during the cardiac cycle, out-of-plane motion can create 
illusory displacement of the true boundary position, which 
can further reduce the volumetric assessment accuracy. Thus, 
the true three-dimensional nature of real-time 3D 
echocardiography (RT3DE) scanning enables to overcome 
these limitations, allowing to entirely visualize the 
morphology of the cardiac chambers. This directly translates 
into increased agreement of RT3DE against the current gold-
standard method (i.e. cMRI) when compared to conventional 
2D echocardiography. Summing this to the intrinsic 
advantages of ultrasound imaging against other modalities, 
RT3DE will likely become the standard echocardiographic 
examination of the future. 
3. CARDIAC IMAGE PROCESSING METHODS 
Additionally to the imaging acquisition, the extraction 
of the relevant information from the data by a software tool 
must be considered. The assessment of volumetric, 
functional and morphologic indices poses two main 
problems. First, a clear identification of the myocardial 
anatomy is needed, through the delineation of the endo- and 
epicardial surfaces at a given time point. Furthermore, the 
position of these boundaries throughout the cardiac cycle is 
needed to recover the underlying motion of the cardiac 
chamber and capture the volume changes. Several methods 
have thus been proposed to address these problems and a 
categorization of these methods is possible dividing into 
geometrical models, shape-free methods, statistical models, 
classification approaches and tracking [3]. Each of these 
categories is briefly described in this chapter. For a more 
comprehensive description of these methods, the interested 
reader can refer to the extensive review by Leung and Bosch 
[3]. 
Geometrical models are the most common border 
detection approaches and consist of the representation of a 
border in terms of a curved surface influenced by 
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geometrical constraints. This surface is initialized 
interactively or automatically and evolves iteratively 
according to image features such as the local intensity or 
edge information. Most geometrical models use energy-
based optimization where a mathematical energy function is 
defined according to the image features and other 
regularization terms and optimized iteratively [62–67]. 
Given the surface representation that is used, the main 
disadvantage of these models lies in finding a balance 
between a surface that is too smooth and one that becomes 
implausible. 
Shape-free methods are, as the name implies, methods 
with little or no dependency on the shape of the final object. 
As such, they are heavily dependent on low-level image 
information such as pixel intensity, gradients, edges and 
corners and motion vectors. The two main families with this 
category are clustering and level sets. Clustering is, simply 
put, a categorization of each pixel of the image into groups, 
for example myocardial tissue and blood pool [68–71]. Level 
sets are similar to geometrical models with the main 
difference that the shape of the object is not restricted, which 
can often result in multiple disconnected surfaces [72–76]. 
Due to the low level of shape restrictions imposed, these 
techniques are quite susceptible to image artifacts such as 
shadowing or dropouts. 
Statistical models are population based methods which 
model the statistical variations of patient data according to 
borders manually contoured by experts. This is done by 
finding a relatively simple mathematical model with but a 
few parameters that can express the patient variability from 
an average. By varying these parameters one can then 
synthetize a large number of shapes. Different sources of 
information can be used to build such a model. Active shape 
models use the manual contoured borders [77–79], whereas 
active appearance models use a combination of the manual 
contoured borders and the image intensity information [80–
82]. Given their origin from real examples this method can 
only find plausible results. However, this is also its downfall 
as the accuracy of the model will always be dependent on the 
quality of the original database and its extension throughout 
both healthy and pathological populations. 
Classification approaches are also dependent on large 
sets of data contoured by experts, with however a different 
approach than statistical models [83–86]. According to the 
database information, a classifier is trained to distinguish the 
objects of interest into classes using appropriate features. In 
practice, parts of an image are then classified by selecting 
regions of different sizes in the image in different positions 
and determining its class following a coarse-to-fine scheme. 
Though the training procedure is extremely time consuming, 
the detection can be very fast. Classification approaches 
suffer from the same disadvantage as statistical models due 
to its dependency on the original database. However, even 
larger datasets are typically needed then for statistical 
models. 
Finally, tracking approaches are the most different from 
the other approaches as they do not aim at the border 
detection itself but at the estimation of the motion of an 
object throughout time. Thus, tracking approaches have a 
more dynamic nature. Since tracking approaches are mostly 
dependent on image information such as pixel intensity, the 
results can be especially sensitive to the presence of artifacts. 
This makes the introduction of information such as cardiac 
motion patterns particularly interesting. The existing 
tracking approaches are usually based on either registration 
or speckle tracking. In registration approaches the spatial 
correspondence between sequential images is found by 
measuring and optimizing a measure of similarity between 
them [64,87–90]. Speckle tracking approaches aim at finding 
a correspondence between speckle patterns throughout time 
[91–99]. 
4. CARDIAC CHAMBER VOLUME ASSESSMENT 
USING 3D ULTRASOUND 
4.1. Left Ventricle 
4.1.1. Available Technology 
Accurate volume measurements require precise 
delineation of the LV endocardial border over the entire 
cardiac cycle. Nonetheless, manual delineation of these 
boundaries in 3D data is a cumbersome and time-consuming 
task, making the introduction of this approach in clinical 
routine impractical. Hereto, several software packages have 
been introduced to aid the clinician in this contouring 
process by providing some form of automation.  
Tomtec Imaging Systems (Unterschleissheim, 
Germany) was the first company presenting commercial 
tools for 3D volume quantification, taking advantage of its 
expertise on image processing and visualization. Their 
current product, TomTec 4D LV-Analysis©, performs an 
automatic orientation of the LV longitudinal axis to display 
three apical and three short axis views. If necessary, these 
can be adjusted by the user to avoid foreshortening and 
modify the aortic valve landmark orientation. The entire 3D 
endocardial surface of the left ventricle is then contoured by 
the software in end-systole and, using 3D speckle tracking, 
propagated throughout the heart cycle [100]. This same tool 
is also available under TomTec’s software solution 4D LV- 
FunctionTM. 
Contrarily to the purely offline approach offered by 
TomTec, Philips Healthcare (Best, Netherlands) introduced 
the possibility of both offline and online analysis with their 
QLAB – 3DQ Advance (3DQA) software suit [101,102]. 
First, the longitudinal axes must be aligned in the 4-chamber 
and 2-chamber views at the end-diastolic phase. Five 
anatomical landmarks must then be marked, which are used 
to initialize a deformable shell model [62]. This model is 
afterwards deformed towards the LV boundaries, with the 
option for manual correction. The same process must be 
completed for the end-systolic phase [102]. Philips 
Healthcare is currently preparing to introduce a new 
commercial tool, HeartModelAI, which will be available on 
their EPIQ7 system and should be released by August 2015. 
The HeartModelAI is a fully automatic knowledge-based 
model which detects end-diastolic and end-systolic 
instances, performs localization and tracking of the four 
chambers and also alignment of the apical 4-, 3- and 2-
chamber views [103]. Refinement of the results is also 
possible through manual correction of the contours. The tool 
returns then the LV and LA volumes at end-systole and end-
diastole. 
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More recently, also General Electric (GE Vingmed, 
Horten, Norway) introduced a software package, 4D 
AutoLVQ, which allows both fully or semi-automated 
segmentation and volume quantification of the left ventricle 
[100]. In this product, an initial alignment of the axis is 
needed so as to avoid foreshortening. This can be performed 
either automatically or manually by pivoting and translating 
the planes. In the semi-automatic version, the user is 
required to mark the location of the apex and the mitral 
annulus at end-diastole and end-systole. After this, the 3D 
endocardial surface is automatically detected at these 
instances. In the fully automatic version no initialization 
points are required. After the conclusion of the segmentation 
the user is allowed to manually edit the contours. 
Toshiba Medical Systems (Tokyo, Japan) has entered 
the RT3DE realm with its ArtidaTM system, which was 
complemented with a software tool for chamber 
quantification by 3D echocardiography speckle tracking, 3D 
Wall Motion Tracking (3D-WMT) [102,104,105]. This 
computational platform performs an automatic selection of 
apical 4-chamber and 2-chamber views, as well as 3 short-
axis views at different LV levels. The user is then required to 
place six markers: at the edge of the mitral valve and at the 
apex in each of the apical planes. These points are then used 
to automatically segment the endocardium. The epicardial 
contour is defined either by a predetermined thickness or 
through manual contouring. The final shape of the left 
ventricle can then be corrected manually by the user. A 3-
dimensional block matching algorithm [106] is then used to 
track the wall motion throughout the cardiac cycle in a fully 
automatic manner. 
The development of a fully automatic image analysis 
software package has been one of the main strategic 
investments of Siemens Medical Solutions (Mountain View, 
California) while developing their Acuson SC2000TM 
RT3DE system, resulting in the software tool eSie LVATM 
[107]. This tool is based on a comprehensive database of 
manually annotated RT3DE exams (over 4000) covering 
both healthy and typical pathological cases in clinical 
practice. The offline learning process was performed using a 
Probabilistic Boosting Tree [108] to obtain the final 
classifier. Given an input volume, this classifier sequentially 
estimates position, position-orientation and full similarity to 
locate the object and finally performs both an orientation 
according to standard planes [86] and also the contouring of 
the LV using boundary detectors [109] and statistical shape 
models. The final endocardial contours can be refined by the 
user through manual correction. 
4.1.2. Validation Efforts 
The enthusiasm generated in the medical community by 
2D matrix transducers and RT3DE is well demonstrated by 
the numerous validation studies for this imaging modality 
over the past decade. Although validation on other 
experimental setups has been done (e.g. water balloons of 
known volume [110], intracavity balloon measurement in 
canine models [111], in vitro porcine heart models [112]), 
the primary and more generalized validation route for the 
existing software suites for volumetric measurement is to 
perform direct comparison of the volumetric indices 
extracted from RT3DE exams against reference values 
extracted from cMRI, which remains the generally accepted 
gold standard method for volumetric assessment of cardiac 
chamber dimensions. Alternatively, some studies report a 
direct comparison between automated vs. manual contouring 
of RT3DE data, thus providing insight on the ability of 
automating the contouring process. The most relevant studies 
are summarized in this sub-section and Table 1 provides an 
overview of the corresponding main results. Figure 2 shows 
an example of LV segmentation in 3D echocardiography 
data. 
 
Figure 2. Example of LV segmentation in 3D echocardiography 
data obtained through a semi-automatic method. a: triplane-view 
and 3D rendering; b: short-axis view; c and d: long axis views. 
Reproduced from [67]. 
The earlier studies focused on software tools which 
relied mostly on a computer-assisted 3D manual contouring 
paradigm, either requiring manual delineation of the 
endocardial boundary in several long axis planes or requiring 
significant user input in semi-automatic segmentation 
algorithms. The performance of the pioneer Volumetrics 
system has been analyzed by both Schimdt et. al [113] and 
Lee et al. [114]. Both studies found excellent correlation 
between cMRI-derived volumetric indices and the ones 
extracted from RT3DE data by manually contouring in 
different azimuthally equidistant long axis images. Note that 
Kühl et al. had already demonstrated that the truly 3D nature 
of RT3DE data enabled long-axis contouring in contrast to 
the short-axis, sum-of-disk approaches initially inherited 
from cMRI [115]. Mannaerts et al. performed a similar study 
with an ATL® HDI 5000 system and manually contouring 
the endocardium using one of the first TomTec tools, Echo-
View. Mannaerts et al. reported good correlation as well as 
the first evidence of a negative bias of 3D echocardiographic 
volumes with respect to cMRI [116]. Kühl et al. performed 
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the first clinical validation on the second generation of 2D 
(i.e. fully sampled) matrix transducers, showing excellent 
correlation against cMRI, in a cohort of 24 good image 
quality patients [117]. In this study, a manual contouring 
paradigm was compared against an early semi-automatic 
algorithm, showing that the tested semi-automated approach 
enabled full 4D delineation but required longer analysis 
times and showed larger bias and wider limits of agreement. 
Jenkins et al. have further validated the same system in a 
larger study (#=50) using a semi-automatic approach 
provided in an earlier version of TomTec’s 4D LV-
Analysis© [118]. The tool required the placement of 
landmarks in 12 azimuthally equidistant long axis views 
which were used to fit an ellipse to the endocardial borders. 
This was then followed by manual refinement. In addition to 
low bias and acceptable limits of agreement, RT3DE showed 
lower test-retest and intra/inter-observer variability than its 
2D counterpart. The same semi-automatic approach was 
validated by Sugeng et al. with excellent correlation against 
cMRI and low bias though with wider limits of agreement 
[119]. Van den Bosch et al. have carried out the first clinical 
validation of RT3DE-derived LV volumes in congenital 
heart disease patients, whose challenging cardiac shapes had 
been previously reported as a difficulty [120]. Their results 
show excellent correlation/agreement for LV volumetric 
analysis using a fully manual contouring approach. 
However, when applying the same semi-automatic 
contouring software tool as used in [118], the results 
highlighted that this tool relied too much on a purely 
elliptical shape prior, thus having a poor performance. 
Despite the strong resilience of the multi-planar contouring 
paradigm in the early clinical validation, a more 3D-oriented 
vision has been introduced with the algorithm proposed by 
Corsi et al. [73], which was further validated by Caiani et al. 
in a clinical setting [76]. 
Jacobs et al. have been the first to validate the concept 
of rapid, online measurement of LV volumes from RT3DE 
data [101], using the tool provided by Philips, QLAB – 
3DQA. Indeed, online volumetric analysis within the 
imaging system without the need to export data to an 
external computer for tracing and 3D reconstruction further 
reduces time load. Very strong correlation and acceptable 
limits of agreement were found for all volumetric indices, 
despite the significant bias for EDV and ESV. Additionally, 
the comparison between the volumetric indices extracted 
online correlated strongly and had good agreement against 
the offline semi-automatic contouring approach proposed in 
[117]. Nonetheless, in a study by Jenkins et al., the offline 
approach by TomTec was compared to Philips’ QLAB – 
3DQA showing that offline approaches remain superior to 
the online quantification of LV volumetric indices, at the 
expense of longer analysis times [121]. A similar study was 
conducted by Soliman et al. using a newer version of 
TomTec’s 4D LV-Analysis© in which only the manual 
contouring of three orthogonal planes is needed and similar 
results as those by Jenkins et al were obtained [122]. In a 
different study by Soliman et al., two different versions of 
TomTec’s 4D LV-Analysis© are compared to volumes 
obtained through cMRI showing strong correlation for both 
methods and a clear superiority of the newer version 
dependent on full volume reconstruction [123]. 
Despite the convincing results of the previous 
validation studies, a clearer understanding of possible 
sources of errors was required for optimal clinical usage. To 
this end, Mor-Avi et al. have studied the source of variation 
between volumetric indices measured with RT3DE and 
cMRI, showing that the fundamental difference is the 
inability of RT3DE to resolve the separation between 
trabeculae and myocardium. Indeed, including the trabecular 
region outside of the blood pool during cMRI contouring in 
the blood pool significantly reduced the RT3DE vs. cMRI 
bias, as well as the limits of agreement [110]. This fact sums 
up with the blurring effect caused by the PSF of the acquired 
ultrasound signal, which pushes the apparent blood-tissue 
interface towards the blood pool, as shown by Mor-Avi et al. 
in balloon phantoms. 
More recently, a shift towards more advanced software 
suites has enabled more automated analysis of RT3DE data, 
allowing a more efficient workflow towards the extraction of 
clinically relevant information from RT3DE data. Indeed, the 
previously cited studies have mostly focused on semi-
automatic software tools that provide at most computer-
aided manual delineation of the LV cavity. Typical time of 
analysis ranged from around 2 min. [101] to 10 min. 
[76,118], although several studies report analysis times 
around 5 min per dataset [110,122]. Note that Jacobs et al. 
have shown that online LV volumetric analysis can provide 
accurate results in less than 2 minutes per volume [101] but 
they stress that manual adjustments were required in 42% of 
the analyzed cases using an online quantification tool, 
increasing the analysis time from 2 minutes to up to 5 
minutes per volume.  
With this in mind, strong research effort has been 
directed towards more efficient software packages, 
incorporating advanced computer algorithms enabling a 
faster, more efficient and more accurate processing of 
RT3DE volumes. Hansegard et al. [124] and Muraru et al. 
[125] used GE’s AutoLVQ and TomTec’s 4D LV-Analysis© 
to show that a more advanced, automated software package 
can reduce the average time of analysis when compared with 
standard semi-automated strategies, while keeping 
comparable accuracy. Muraru et al. [125] has equally shown 
that fully automated (i.e. only manual initialization on ED 
and ES frames, with subsequent automatic delineation) is 
feasible. However, their results show that a noticeable 
increased agreement can be achieved by manually adjusting 
the results from an automated method, at the cost of 
doubling the total analysis time. Kleijn et al. have validated 
another highly automated software tool, Toshiba’s 3D-WMT 
[126]. Despite only moderately good results for the LV 
volume assessment, the EF results showed excellent 
correlation and remarkably low bias and limits of agreement, 
indicating that more advanced tracking methods can 
positively influence the quality of the extracted surfaces 
when compared to pure contour-extraction approaches. 
Similar results have been reported by Kawamura et al. [105]. 
To test the potential of RT3DE in a realistic clinical 
scenario, Miller et al. analyzed 60 consecutive patients to 
determine the effect of image quality in RT3DE volume 
quantification performance [127]. Despite reporting lower 
agreement with cMRI measurements than previously found, 
the authors stress that the degree of error is intrinsically 
linked with image quality. 
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Using Siemens’ eSie LVATM tool, Thavendiranathan et 
al. demonstrated that fully automatic analysis of RT3DE is 
possible and presents extremely encouraging results [128]. 
Note that Thavendiranathan et al. point out that the patients 
undergoing RT3DE exams in the analyzed dataset were 
selected for good acoustical windows, thus holding good 
imaging quality. The authors have applied the same 
computational automatic analysis algorithm to the 
reconstructed cMRI datasets and have found slightly higher 
bias and limits of agreement against the manual delineation 
on cMRI data than when using the same software on RT3DE 
data (-0.8±4.7% vs. -0.3±2.5%). This seems to point towards 
the excellent image quality of the analyzed RT3DE dataset. 
Similar results have also been published by Zhang et al. 
[129]. Using the same tool, Chang et al. [130] reported 
slightly lower correlations and the Bland-Altman analysis on 
EF estimates revealed much larger bias and limits of 
agreement than reported by Thavendiranathan et al. in [128]. 
Nonetheless, it is important to stress that the dataset 
corresponded to consecutive patients, although previously 
selected based on 2D echo image quality and the user was 
allowed to manually correct the automatically detected 
contours. It should also be noticed that Chang et al. report 
that automatic results were considered excellent in 11% of 
the cases (i.e. not requiring any adjustment), good (i.e. five 
or fewer manual corrections required) in 34% of the cases 
and it failed completely (i.e. required manual delineation) in 
10% of the cases. Regarding the influence of manual 
correction, Shibayama et al. have evaluated the same system, 
performing firstly fully automatic analysis and then allowing 
the user to proceed to manual corrections, in a cohort of 44 
consecutive patients [131]. Their results reinforce the 
findings of Muraru et al. for a different system, thus 
highlighting that even state-of-the-art software packages are 
not yet able to consistently perform fully 
automated/automatic analysis of RT3DE data. Indeed, 
Shibayama et al. show that fully automatic results are 
significantly improved through manual interaction. 
Nonetheless, manual correction increased the total analysis 
time by a factor of 10. Using Philips’ HeartModelAI tool, 
Tsang et al. have analyzed 46 patients achieving similar 
results to those reported with other fully automatic 
approaches without performing manual correction of the 
contours [132]. 
The key summary of the literature on the clinical 
validation of RT3DE volumetric assessment against cMRI 
can also be appreciated in the recent meta-analysis studies of 
Shimada and Shiota [133] and by Dorosz et al. [134]. 
Shimada and Shiota’s meta-analysis included 3055 subjects 
in 95 studies, focusing not only on 2D matrix transducers but 
also earlier systems based on mechanical steering. A key 
evidence is the significant underestimation bias of left 
ventricular volumes (both EDV and ESV) by RT3DE 
compared with cMRI. On the other hand, no statistically 
significant bias for estimation of EF was found. Sources of 
error included gender and presence of congenital heart 
disease, which were associated with more underestimation in 
the analysis. Semi-automatic border detection and the use of 
matrix-array transducers were associated with less 
underestimation. As key conclusion, the studied literature 
supports the role of RT3DE as both accurate and 
reproducible in assessing left ventricular volumes and EF, 
although it is not interchangeable with other radiologic 
modalities. On the meta-analysis study by Dorosz et al., also 
an additional perspective on how RT3DE compares with 
conventional 2D echocardiography is given in parallel to the 
central comparison of RT3DE-derived volumetric indices 
against cMRI. Their main conclusion is that RT3DE 
underestimates volumes and has wide limits of agreement, 
but compared with traditional 2D methods, it is more 
accurate (i.e. smaller bias) for volumes (EDV and ESV) and 
more precise (i.e. tighter limits of agreement) for EDV, ESV 
and EF measurements. One of the key benefits of RT3DE is 
the reduction in intra/interobserver variability, which is 
important for clinical practice, since disease progression in a 
patient will be most likely assessed serially by different 
readers. Dorosz et al. also highlight the natural influence of 
image quality on the estimation of LV volumetric indices. 
Indeed, an analysis of those studies that accepted all 3D 
datasets, instead of selecting patients for image quality, 
shows that the 95% limits of agreement against cMRI raise 
from ±34 to ±38ml for EDV, ±30 to ±34ml for ESV and ±12 
to ±15% for EF. 
At last, the first step towards effective clinical 
integration of 3D echo volume measurements is the 
population-based assessment of normal values, as 
acknowledged recently by Marwick in the editorial note of a 
leading cardiovascular imaging journal [135]. Several 
studies, including the work of Aune et al. [136], Kaku et al. 
[137], Fukuda et al. [138], Chahal et al. [139] and Muraru et 
al. [140], have been filling this gap, providing clinicians one 
of the last pieces of the path towards clinical integration of 
RT3DE examination in daily routine. An ongoing large-scale 
project (EchoNoRMAL) is aiming to define the 
echocardiographic normal ranges of the LV, through a 
collaborative effort meta-analysis approach [141,142]. 
4.2. Left Atrium 
4.2.1. Available Technology 
Given the low priority given to LA volume and 
function assessment, the solutions dedicated to LA 
segmentation are limited. TomTec was the first to 
commercialize a dedicated tool: 4D LA-Analysis©. Similarly 
to an earlier version of TomTec’s 4D LV-Analysis©, the user 
is asked to manually contour the endocardium in three 
different views (2-, 3- and 4-chamber) at both ED and ES 
frames. A polyhedral mesh is then generated for each of 
those frames by volumetric interpolation of the 2D contours 
and temporal smoothing is performed, resulting in a smooth 
volume curve for the whole cardiac cycle. The mesh volume 
calculation excludes the mitral valve tenting volume, whose 
limit is that defined by the mitral valve points introduced by 
the user. The user can also manually adjust the segmentation 
results [143,144]. This same tool is also available under 
TomTec’s software solution 4D LA-Function©. 
Until recently, no other dedicated tool was available 
besides TomTec’s. Philips’ fully automatic HeartModelAI 
tool, released on August 2015, will change that, as it also 
provides LA volumes besides LV (cf. Section 4.1.1.) [103]. 
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Table 1. Literature Overview: Validation of RT3DE and commercial software tools for LV volumetric assessment (#: number of exams; Ref: 
reference measurements taken from cMRI or manual contouring of RT3DE data (3DM); r: correlation coefficient; BA Bland-Altman 
analysis).




input # Ref Time (s) 
r BA (µ±2σ) 
EDV ESV EF EDV ESV EF 
Schimdt et al., 
1999 [113] Volumetrics - A(NR) 25 cMRI 120-180 0.88 0.82 NR NR NR NR 
Lee et al., 2001 
[114] Volumetrics - A(7) 25 cMRI NR 0.99 0.99 0.92 NR NR NR 





EchoView4.2 A(9) 28 cMRI 
1200-
1800 0.79 0.90 0.87 -27.9±45.7 -34.4±45.5 1.2±15.8 
Kühl et al., 2004 
[117] 
Sonos 
7500+X4 - C(24.2) 24 cMRI 720±300 0.98 0.98 0.98 -13.6±37.8 -12.8±41 0.9±8.8 
Kühl et al., 2004 
[117] 
Sonos 
7500+X4 - C(24.2) 24 3DM 720±300 0.99 0.99 0.98 -1.3±17.2 -0.2±10.8 -0.1±5.4 





4DLVA C(36.2)+R 50 cMRI 630±60 NR NR NR -4±58 -3±36 0±14 
Caiani et al., 
2005 [76] 
Sonos 
7500+X4 - B(4)+R 44 cMRI ~300 0.97 0.97 0.93 -4.1±30 -3.5±34 -0.8±14 





EchoView5.2 A(8) 29 cMRI 1020±300 0.97 0.98 0.94 -2.9±12 0.9±9.9 -1.4±7.2 





4DLVA 1.2 C(24.2) 29 cMRI 360±120 0.79 0.84 0.54 NR NR NR 





3DQA C(5.2)+R 50 cMRI 120-420 0.96 0.97 0.93 -14±34 -6.5±32 -1±12.8 





4DLVA C(36.2)+R 110 cMRI 630±60 0.86 0.91 0.81 -15±56 -10±44 1±16 





3DQA C(5.2)+R 110 cMRI 240±20 0.78 0.86 0.64 -44±70 -21±56 -2±20 





4DLVA C(18.2)+R 31 cMRI NR 0.97 0.96 0.96 -5±53 -6±53 0.3±8 





4DLVA 2.0 B(3)+R 41 cMRI 360±120 0.99 0.99 0.98 -9.4±8.9 -4.8±10.1 0.3±4.7 





3DQA C(5.2)+R 41 cMRI 240±20 0.99 0.98 0.97 -16.4±13.4 -8.5±14.2 0.7±6.3 





4DLVA 1.2 C(24.2)+R 53 cMRI 900±300 0.96 0.98 0.95 -24.0±9.4 -11.3±17.2 0.8±6.4 





4DLVA 2.0 B(3)+R 53 cMRI 360±120 0.99 0.99 0.98 -9.9±8.4 -5.0±9.6 0.6±4.8 
Mor-Avi et al., 
2008 [110] iE33+X3-1 
QLAB - 
3DQA C(5.2)+R 92 cMRI ~300 0.91 0.92 0.81 -67±92 -41±92 -3±22 
Muraru et al., 
2010 [125] Vivid7+3V 
4D 
AutoLVQ C(9.2) 23 cMRI 48±24 0.77 0.72 0.64 -32.3±43.6 -13.9±30.7 -1.5±12.8 
Muraru et al., 
2010 [125] Vivid7+3V 
4D 
AutoLVQ C(9.2)+R 23 cMRI 112±30 0.93 0.95 0.85 -11.0±24.2 -9.1±14.2 -2.9±8.4 
Muraru et al., 
2010 [125] Vivid7+3V 
TomTec 
4DLVA 2.0 B(3)+R 23 cMRI 226±84 0.96 0.94 0.85 -8±19 -7±13 2.8±8.4 
Chang et al., 
2011 [130] SC2000+4Z1c eSie LVA
TM
 D+R 91 cMRI NR 0.91 0.94 0.91 -41.38±37.2 -7.91±33.7 -8.26±13.0 
Thavendiranathan 
et al., 2012 [128] SC2000+4Z1c eSie LVA
TM
 D 91 cMRI 30-60 0.90 0.96 0.98 -17.6±53.4 -9.8±35.8 -0.3±5.0 
Kleijn et al., 2012 
[126] 
Artida4D+PST-
25SX 3D-WMT C(5.2) 45 cMRI 
~300 (w/ 
acq.) 0.75 0.81 0.91 -34±50 -13±22 -0.6±2.4 
Miller et al., 2012 
[127] iE33+X3-1 
QLAB - 
3DQA C(5.2)+R 42 cMRI 306±60 0.83 0.84 0.77 -45±70 -11±48 -7±18 
Shibayama et al., 
2013 [131] SC2000+4Z1c eSie LVA
TM
 D 41 cMRI 36±8 0.80 0.85 0.54 -22.2±73.0 -18±64.2 1.2±23.3 
Shibayama et al., 
2013 [131] SC2000+4Z1c eSie LVA
TM
 D+R 41 cMRI 371±116 0.96 0.97 0.9 -4.4±34.9 -5±27.7 0.9±15.2 
Tsang et al., 2013 
[132] X5-1 HeartModel
AI
 D 46 cMRI <5 0.89 0.94 0.93 -35.05±90.34 -24.95±86.84 0.55±11.62 
Zhang et al.,2013 
[129] SC2000 eSie LVA
TM
 D 60 cMRI NR 0.89 0.93 0.71 -3.5±43.5 -0.07±33.2 -2.7±15.7 
Kawamura et al., 
2014 [105] Artida 3D-WMT C(5.2)+R 64 cMRI NR 0.86 0.85 0.74 -19.0±76.5 -10.1±70.4 -0.3±13.1 
User input: A(X): Computer assisted delineation of the 3D surface via manual contouring of X 2D planes; B(X): Semi-automatic segmentation, with manual 
initialization by contouring in X 2D planes; C(L,F): Automated segmentation, with user input of L anatomical landmarks in F time frames; D: Fully automatic 
segmentation without any user intervention; R: Manual refinement of segmentation results. 
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Apart from these tools, other LA quantification 
solutions still rely on the use of generic tools, primarily 
designed for LV volumetric quantification. With this regard, 
the use of QLAB – 3DQA (Philips) [102,145,146], and 3D-
WMT (Toshiba) [102], and eSie LVATM (Siemens) [147] for 
quantification of LA volume has been reported. The 
description of aforementioned tools can be found in Section 
4.1.1.. The current eSie LVATM fully automated solution is 
based on the database-driven knowledge-based approach, 
which relies on learned features from LV shape, appearance 
and motion. As such, it seems to not be suited for LA 
volume analysis. However, a semi-automated version was 
available and has been used for LA volume assessment 
[147]. 
4.2.2. Validation Efforts 
The recent efforts towards clinical validation of 3D 
echocardiographic assessment of LA volumes have been 
reflected in the latest Recommendations for Chamber 
Quantification [148]. A summary of the validation studies 
found in literature are presented in this section and Table 2 
presents the corresponding results. Figure 3 shows an LA 
segmentation example on a 3D echocardiography image. 
To et al. [6] address the strengths and weaknesses of 
different imaging modalities (2D and 3D echocardiography, 
cMRI and CT) in the assessment of LA morphology and 
function. In this review, 3D echocardiography is considered 
comparable to the other modalities regarding the estimation 
of static dimensions, and superior in the estimation of phasic 
size, and LA mechanics. In addition, the authors note the 
current indications of echocardiography for LA assessment 
(first-line diagnostic evaluation and follow-up) and other 
potential indications (serial monitoring and detailed 
functional assessment of LA phasic function).  
Miyasaka et al. [145] demonstrated the added value of 
3D echocardiography to derive LA volumes, in a study 
including 57 patients, with multi-detector CT as gold-
standard. The volume underestimation typically observed in 
echocardiographic measurements was significantly lower for 
LAmax volumes derived from 3D echocardiography, 
compared to those estimated from 2D echocardiography. 
Rohner et al. conducted a similar study using TomTec’s 4D 
LA-Function© also showing good correlation between CT 
and RT3DE values [149]. The underestimation of volumes 
was in this study, however, much larger. A multicenter study 
(92 patients with a large range of LA volumes) conducted by 
Mor-Avi et al. [143] showed that LAmin and LAmax 
volumes from 3D echocardiography also correlate better 
with cMRI, compared to 2D. Moreover, statistically 
significant underestimation of volumes was observed on 2D 
and not on 3D measurements. In the same study, 3D 
echocardiography also improved classification of enlarged 
atria, while intra- and inter-observer variability was similar. 
The volumetric measurements reported in this study were 
obtained using the semi-automated 4D LA-Function© tool 
(Tomtec). 
An extensive analysis of different techniques to derive 
LA volumes from echocardiography (both 2D and 3D) is 
presented in [146], including data from 60 patients. The 3D 
images were analyzed with two semi-automatic tools: 
TomTec’s 4D LA-Analysis© and Philips’ QLAB – 3DQA, 
which was built primarily for LV segmentation. Although all 
volumes derived from echocardiography were 
underestimated compared to cMRI, reported bias ranged 
from -50.5% down to -4.7% across the different techniques. 
The following techniques estimated LAmax and LAmin 
volumes with increasing accuracy (sorted from the highest to 
the lowest bias): 2D prolate ellipsoid method; 3D semi-
automated generic tool (QLAB – 3DQA); 2D area-length 
method; 2D bi-plane Simpson method; 3D manual specific 
tool (4D LA-Analysis©). These results suggest that, despite 
the previously shown importance of 3D data, the accuracy 
may vary significantly depending on the methodology (semi-
automated vs. manual or generic vs. LA-specific tools). 
Another study using a generic semi-automated tool, 
eSie LVATM, to assess LA volumes from 3DE shows 
alarmingly inaccurate results [147]. It must be noted 
however that this study included only atrial fibrillation 
patients, which are typically more challenging to image and 
analyze, and that this tool was primarily designed for LV 
segmentation. Therefore, image quality played a very 
important role on such results (poor correlation with CT for 
both 2D and 3D echocardiography measurements). 
Nonetheless, LA volume was also significantly 
underestimated in a sub-group of recordings with good 
image quality (-44% for 2DE and -21% for 3DE). 
 
 
Figure 3. LA segmentation example in a 3D echocardiography image using a semi-automated algorithm [150]. a and b: long axis views; c: 
triplane-view and 3D rendering. 
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Finally, a comparison between two standard echo-
analysis tools, QLAB – 3DQA (Philips)  and 3D-WMT 
(Toshiba), was performed in a large study including 120 
subjects (both unselected patients and healthy volunteers) 
[102]. The results were in close agreement for both LAmax 
and LAmin, and showed equally good inter- and intra-user 
reproducibility, suggesting its interchangeability. It should 
be noted however that this refers only to the comparison of 
echo-based measurements, without an independent modality 
as reference. 
The use of LA-specific fully automatic tools has been 
reported in a single validation study by Tsang et al. using 
Philips’ HeartModelAI tool. The results are promising, 
showing good correlation with volumes obtained from cMRI 
though somewhat below the performance reported for other 
LA dedicated semi-automatic tools [132]. 
In summary, echocardiography is a reliable modality 
for LA volume assessment (albeit its typical underestimation 
compared to CT or cMRI). Volume measurements from 3D 
echocardiography are consistently more accurate and less 
user-dependent than those from 2D as pointed out in the 
recommendations by Lang et al. [148]. Image quality and 
LA-specificity of automated tools are important factors 
influencing the reliability of the measurements. LA phasic 
function assessment from 3D echocardiography still lacks 
validation, despite having been used in some clinical studies. 
 
Table 2. Literature Overview: Validation of RT3DE and commercial software tools for LA volumetric assessment (#: number of exams; Ref: 
reference measurements taken from cMRI or manual contouring of RT3DE data (3DM); r: correlation coefficient; BA Bland-Altman 
analysis). 
Study Imaging System 
Analysis 
system User input # Ref 
Time 
(s) 
r BA (µ±2σ) 
LAmax LAmin EF LAmax LAmin EF 
Miyasaka et al., 
2011 [145] iE33+X3-1 QLAB - 3DQA C(5,2)+R 57 CT 300-600 0,95 NR NR -2.5±3.6 NR NR 
Rohner et al., 2011 
[149] iE33+X3-1 
TomTec 
4DLAF B(3) 34 CT NR 0.92 0.95 0.82 -24.8±40.6 -25.2±39.0 8.6±18.4 
Mor-Avi et al., 2012 
[143] iE33+X3-1 
TomTec 
4DLAF B(3) 92 cMRI NR 0.93 0.88 NR -1±28 0±43 NR 





4DLAA B(3) 55 cMRI NR 0.93 0.95 0.92 -7.2±21.8 -7.2±20.0 1.8±17.7 





4DLAA B(3) 60 cMRI 161±29 0.94 0.95 NR -5±24 -6.5±20 NR 
Buechel et al., 2013 
[146] 
iE33+X3-
1/X5-1 QLAB - 3DQA C(5,2)+R 60 cMRI 144±19 0.80 0.90 NR -17±33 -11±27 NR 
Tsang et al., 2013 
[132] X5-1 HeartModel
AI
 D 46 cMRI <5 0.91 NR NR -10.26±32.30 NR NR 
Heo et al., 2014 
[147] SC2000 eSie LVA
TM
 NR 31 CT NR 0.23 NR NR NR NR NR 
User input: A(X): Computer assisted delineation of the 3D surface via manual contouring of X 2D planes; B(X): Semi-automatic segmentation, with manual 
initialization by contouring in X 2D planes; C(L,F): Automated segmentation, with user input of L anatomical landmarks in F time frames; D: Fully automatic 
segmentation without any user intervention; R: Manual refinement of segmentation results. 
4.3. Right Ventricle 
4.3.1. Available Technology 
Recently, Tomtec Imaging Systems 
(Unterschleissheim, Germany) has made available an offline 
tool for semi-automatic RV function assessment, 4D RV-
Function© [151]. Firstly, the correct anatomical axis must be 
defined by the user and landmarks placed in both the 
tricuspid and mitral valves and the apex. The end-diastolic 
and end-systolic phases must then be identified and the 
endocardial borders manually contoured on the 4-chamber, 
sagittal and coronal views on both phases. The software then 
automatically delineates the RV endocardial border along the 
heart cycle. The results can be refined by the user at the end 
of this step. A number of measurement values are then 
available for the user namely 3D volume measurements (RV 
EDV, ESV, EF and SV), strain analysis and 2D standard 
measurements [151]. Both GE Vingmed and Siemens 
Medical Solutions have recently made this tool available in 
their systems thanks to a strategic cooperation with TomTec 
Imaging Systems. Figure 4 shows an in-program screenshot 
of 4D RV-Function© in the contour revision step. 
Ventripoint Diagnostics Ltd. (Bellevue, United States) 
has introduced the Ventripoint Medical SystemTM [152]. 
This system relies on a 3D RV reconstruction from a 
freehand acquisition using a standard 2D probe with a 
magnetic localizing system. After acquisition of sufficient 
2D planes for a good coverage of the RV (10 to 15 views) 
the end-diastolic phase is automatically defined according to 
the electrocardiographic R wave and the end-systolic phase 
is defined manually by the user. An offline analysis is then 
required, namely the identification of anatomic landmarks 
(ideally 17 to 23 points) after which a database of 3D RV 
shapes is used to define the  RV shape using a piecewise 
smooth subdivision surface reconstruction [152]. 
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Figure 4. TomTec 4D RV-Function© screenshot (Courtesy of 
Guido Claessen, Laboratory on Cardiovascular Imaging and 
Dynamics, KU Leuven, Belgium). 
4.3.2. Validation Efforts 
Though the importance of assessing RV function 
assessment has long been recognized, the lack of literature 
found for RV segmentation in echocardiography is striking, 
especially when compared to the extensive literature found 
for the LV. This can be justified by a series of different 
factors. First of all, the very acquisition of the RV is often 
quite challenging in 3DTE due to its position and shape 
[153]. The sternum and lung tissue can shadow the imaging 
of the RV anterior wall and outflow tract and an attempt to 
avoid this shadowing frequently results in part of the anterior 
wall not being included in the field of view [154]. Secondly, 
the anatomical complexity and asymmetric shape of the RV 
make an automatic segmentation an extremely challenging 
task. The heavy trabeculation found in the RV and the thin 
myocardial wall can also increase the difficulty when 
assessing the volume [155]. Finally, the perceived greater 
importance of the left heart has forced most research to be 
directed towards LV and LA segmentation, thus demoting 
RV analysis to a field of study of lesser importance. In this 
section some of the studies focused on the validation of RV 
volume assessment by 3D echocardiography are summarized 
and Table 3 show the corresponding results. 
The first efforts for RV volume/function assessment 
were, of course, developed for 2D echocardiography. An 
example of this is the tricuspid annular plane systolic 
excursion (TAPSE) introduced by Kaul et al. [156]. This 
measure extracted from a 4-chamber view is shown to 
correlate to RV volumes obtained from radionuclide 
angiography and is still common in today’s clinical practice 
[148]. Nevertheless, Helbing et al. have shown, by 
comparison with cMRI volumes, that due to the 
asymmetrical shape of the RV, 2D echocardiography is not 
sufficient to assess the RV volumes [157]. Gopal et al. go a 
step further by comparing volumes assessed through manual 
contouring of 3DTE images of the RV with 2D estimated 
volumes and volumes determined by cMRI, concluding that 
3D echocardiography is superior to 2D for RV volume 
assessment [158]. Two studies, by Jenkins et al. and van der 
Zwaan et al., compare once more 2D and 3D 
echocardiography to cMRI for RV volume assessment 
though now using 4D RV-Function© to determine the 3D RV 
volumes [159,160]. Both studies are in agreement that 
RT3DE not only is superior to the two-dimensional methods 
but also has a greater reproducibility. A single study by 
Kjaergaard et al. claims that 3D echocardiography brings no 
advantage from 2D when compared to cMRI assessed 
volumes [161]. Later studies however propose that this 
conclusion is merely a result of the older 3D 
echocardiographic platform used and the population chosen 
[160]. 
In a compromise between 2D and 3D 
echocardiography, some authors have used 3D 
reconstruction of 2D echocardiographic planes to image the 
whole shape of the RV. Linker et al. have used 3D 
reconstruction of 2D images of ex vivo hearts to manually 
contour the RV endocardium [162]. This was shown to 
correlate with the reference volume obtained by measuring 
the volume of water required to fill the RV. The 3D 
reconstruction system commercialized by Ventripoint 
Diagnostics Ltd. is compared in two clinical studies to RV 
volumes obtained by cMRI showing a good correlation 
between the two [152,163]. 
The accuracy of manual contouring of the RV in the 3D 
echocardiography has been validated in a number of 
different frameworks but the gold standard for RV volume 
assessment remains cMRI. Some of the approaches include 
models from excised animal or human hearts [37,164–168], 
in vivo measurement by intracavity balloon [169], 
thermodilution [170] and intraoperative measurements using 
injections of saline solution [171]. Comparisons of manual 
contouring of the RV in 3D echocardiography are also 
numerous. The first effort for validation of RV manual 
contouring against cMRI was conducted by Vogel et al. 
using a rotating one-dimensional array probe and performing 
manual contouring in parallel planes along the long axis 
[172]. Similar studies were published by Fujimoto et al. 
[173] and Papavassiliou et al. [174] all with good correlation 
values between 3D echocardiography and cMRI. Prakasa et 
al. performed the first validation of RV manual contouring in 
full matrix transducer imaging using both a Sonos 7500 and 
a Philips iE33 [175]. The manual contouring was performed 
in only two orthogonal long axes planes which accounts for 
the low correlation values obtained and large bias, especially 
for EDV. In a study by Nesser et al., RV manual contouring 
was compared to cMRI in both transthoracic (TTE) and 
transesophageal (TEE) acquisitions [176]. Manual 
contouring was done in this study in 10 to 12 azimuthally 
equidistant planes. Results highlight better correlation and 
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bias for the TEE approach which are explained by the better 
image quality. However, the TTE approach also presents 
very competitive values. Lu et al. have used TomTec’s 4D 
Echo-View tool to perform manual contouring of the RV in 
5mm contiguous planes and compared the volumes obtained 
to cMRI reference also with good results [177]. 
The validation of the semi-automatic method 4D RV-
Function© developed by TomTec Imaging Systems has also 
been a subject of some attention and has been compared 
against cMRI RV volumes in some studies.  A first effort 
was performed by Niemann et al. using a prototype of the 4D 
RV-Function© tool which depended on a single manual 
contouring in one plane [178]. The software then 
reconstructed the contours in the orthogonal planes and 
manual refinement could then take place. Results show good 
correlation for the RV volumes against manual contouring of 
cMRI volumes although the EF results are not so 
competitive. Niemann et al. also used the prototype 4D RV-
Function© to contour the cMRI images obtaining excellent 
correlation, bias and limits of agreement. The actual 4D RV-
Function© tool was validated against cMRI by Grewal et al. 
obtaining good correlation values [179] but also by van der 
Zwaan et al. [151], Leibundgut et al. [180] and Zhang et al. 
[181]. In spite of presenting good correlation values, the 
results from van der Zwaan et al. are the most striking by 
revealing the severe underestimation of the RV volumes by 
3D echocardiography. Finally, Ostenfeld et al. have used the 
same commercial tool with and without performing manual 
refinement after the semi-automatic contouring and 
compared the obtained RV volumes against cMRI [154]. 
Besides again evidencing the volume underestimation that 
results from 3D echocardiography, and similarly to what was 
shown by Shibamaya et al. for the LV commercial 
approaches, Ostenfeld at al. show that manual correction is 
still necessary for better results to be achieved. 
In regard  to the reference values for RV volumes, 
several studies have published values in different 
populations. Gopal et al. [158] presented a study of the 
normal RV volumes performed in 71 healthy patients using 
manual contouring and disk summation. Tamborini et al. 
[182] studied 245 subjects divided by age and gender 
performing the contouring using TomTec’s 4D RV-
Function© tool. A more extensive study was conducted by 
Maffessanti et al. including 540 healthy adults again using 
the tool by TomTec for semi-automatic contouring and 
reporting age-, body size- and sex-specific reference values 
for RV volumes and RV EF [183]. 
4.4. Right Atrium 
To the best knowledge of the authors, there is at this 
point no commercial solution or validation studies for 
automatic or semi-automatic RA volume assessment. 
 
Table 3. Literature Overview: Validation of RT3DE and commercial software tools for RV volumetric assessment (#: number of exams; Ref: 
reference measurements taken from cMRI or manual contouring of RT3DE data (3DM); r: correlation coefficient; BA Bland-Altman 
analysis).  




input # Ref 
Time 
(s) 
r BA (µ±2σ) 
EDV ESV EF EDV ESV EF 
Vogel et al., 
1997 [172] Vingmed800 - A(2mm) 16 cMRI NR 0.95 0.751 NR NR NR NR 
Fujimoto et al., 
1998 [173] 
SSH160A+486
CPU - A(2mm) 15 cMRI NR 0.94 0.97 0.90 NR NR NR 
Papavassiliou et 
al., 1998 [174] Sonos2500 - 
A(3-
3.5mm) 13 cMRI NR 0.95 0.95 0.8 -9.6±31.0 -4.3±27 -3.9±14.6 
Prakasa et al., 
2006 [175] 
Sonos7500/iE3
3 TomTec A(2) 43 cMRI NR 0.5 0.72 0.88 -15.9±35.6 -6.8±17.8 NR 





12) 20 cMRI NR 0.85 0.86 0.86 -1.6±36.4 0.1±26.8 -2.0±18.8 





12) 20 cMRI NR 0.86 0.88 0.84 -1.3±35.6 2.8±30.4 -4.0±19.4 
Niemann et al., 




B(1)+R 30 cMRI 600 0.93 0.92 0.68 -0.44±25.40 1.01±7.75 -1.56±13.39 
Lu et al., 2008 
[177] Sonos7500+X4 
TomTec 4D 
EchoView A(5mm) 17 cMRI NR 0.98 0.96 0.89 -7.0±18.0 -3.2±14.2 0.3±8.2 
Grewal et al., 
2010 [179] iE33 
TomTec 
4DRVF B(3)+R 25 cMRI NR 0.88 0.89 0.89 NR NR NR 
Leibundgut et 
al., 2010 [180] iE33+X3-1 
TomTec 
4DRVF B(3)+R 88 cMRI NR 0.84 0.83 0.72 -10.2±21.6 -4.5±14.8 -0.4±7.6 
Van der Zwaan 
et al., 2010 
[151] 
iE33+X3-1 TomTec 4DRVF4.0 B(3)+R 50 cMRI 126±30 0.93 0.91 0.74 -34±66 -11±56 -4±13 





4DRVF B(3) 53 cMRI NR 0.769 0.773 0.488 -32±52 -8±34 -6±18 





4DRVF B(3)+R 53 cMRI NR 0.779 0.835 0.597 -22±52 -7±32 -2±16 
Zhang et al., 
2013 [181] SC2000+4Z1c 
TomTec 
4DRVF B(3)+R 59 cMRI NR 0.97 0.96 0.71 -2.16±15.40 -2.6±16.12 0.86±16.32 
User input: A(X): Computer assisted delineation of the 3D surface via manual contouring, where X is the number of 2D planes contour or the distance between 
parallel 2D planes contoured; B(X): Semi-automatic segmentation, with manual initialization by contouring in X 2D planes; C(L,F): Automated segmentation, 
with user input of L anatomical landmarks in F time frames; D: Fully automatic segmentation without any user intervention; R: Manual refinement of 
segmentation results. 
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5. CLOSING REMARKS 
The assessment of cardiac chamber volume is a 
fundamental task in both clinical and research context to 
obtain a unique insight into the heart function and has been 
shown to have a strong diagnostic and prognostic value in 
numerous instances. Among the different heart imaging 
modalities, RT3DE reveals itself as an excellent technique as 
it allows a true three dimensional imaging of the heart while 
maintaining a relatively low cost and portability and without 
the need for exposure to ionizing radiation. However, the 
nature of RT3DE make it a particularly challenging image 
analysis task. For these reasons, a great effort has been made 
towards RT3DE image analysis and retrieval of its important 
clinical information. Semi-automatic approaches are the 
most common but, recently, attention has been shifting to 
more automatic ones and special attention is being devoted 
to implementing these solutions in real-time. The use of prior 
information and population-based methods are particularly 
promising with new approaches reaching the field in the last 
years. 
Because most attention has been directed towards the 
LV, the development of methods for the remaining heart 
chambers has been more scarce in spite of the fact that the 
assessment of function of these chambers is of indisputable 
clinical importance. Nevertheless, the advances already 
achieved with LV will facilitate the implementation of new 
methods for these chambers, with methods being transported 
and adapted from one chamber to the other. 
Though not in the scope of this work, the advances with 
RT3DE image acquisition also play a powerful role in taking 
this field further. It is expected that, in the future, better 
image quality will be possible with both higher frame rates 
and higher spatial resolution. This will not only make cardiac 
function assessment through RT3DE a more accessible goal 
but will also give access to new information making RT3DE 
an even more powerful tool. 
In conclusion, it can be expected that the importance of 
cardiac function assessment by RT3DE will continue to rise 
as technology evolves and novel, more sophisticated and 
automated approaches arise in the field making RT3DE an 
undeniable tool in clinical practice. 
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